Stock Market & Financial Investment News

News Breaks October 8, 2012 08:31 EDT OPTR Optimer to sell remaining ownership in Optimer Biotechnology for $60M Optimer announced the sale of its stake in Optimer Biotechnology to current OBI shareholders. The sale is expected to result in gross proceeds to Optimer of $60M and will be used to support the commercialization of Dificid tablets and for other corporate purposes. The transaction is expected to close in two phases, subject to customary closing conditions and the completion of administrative matters. The first closing is expected to take place in the fourth quarter of 2012 and the second closing is expected to take place in the first quarter of 2013. News For OPTR From The Last 14 Days Check below for free stories on OPTR the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 15, 2013 16:00 EDT OPTR Optimer calls active following takeover report Optimer (OPTR) May and June 17 calls are active on 5,600 contracts (500 puts) according to Track Data. Traders are taking positions for large price movement on Cubist (CBST) offered to buy the company for $20 per share, Reuters says. 15:54 EDT OPTR Optimer up 12.5%, to $16.03 after Reuters report Cubist offered $20 per share Subscribe for More Information 15:53 EDT OPTR Cubist offered to buy Optimer for $20 per share, Reuters says Subscribe for More Information May 14, 2013 11:41 EDT OPTR High option volume stocks: DANG RLGY JNY TTWO OPTR May 13, 2013 16:53 EDT OPTR Optimer gets bids from AstraZeneca, Cubist, Astellas, Bloomberg says Optimer (OPTR) has received first round bids from AstraZeneca (AZN), Cubist (CBST), and Astellas, reports Bloomberg, citing people familiar with the matter. Shares of Optimer spiked higher following the report, closing up $1.85, or 14.44%, to $14.66. The report notes the company disclosed almost three months ago it was exploring its strategic options. Reference Link 16:08 EDT OPTR Optimer appoints Eric Sirota as COO Optimer Pharmaceuticals announced the appointment of Eric Sirota as COO. Sirota has served as a consultant to the company since March 8. 15:56 EDT OPTR Optimer jumps 13% to $14.43 after Bloomberg report on bidding process Subscribe for More Information 15:55 EDT OPTR Optimer gets first round bids from AstraZeneca, Cubist, Bloomberg says Subscribe for More Information 10:58 EDT OPTR High option volume stocks: PRGO OMEX SCTY OPTR DNR Subscribe for More Information May 10, 2013 16:29 EDT OPTR On The Fly: Closing Wrap Subscribe for More Information 12:31 EDT OPTR On The Fly: Midday Wrap Subscribe for More Information 11:21 EDT OPTR High option volume stocks: UBNT FTK ABFS OPTR IRBT Subscribe for More Information 07:04 EDT OPTR Optimer downgraded to Hold from Buy at Needham Subscribe for More Information 06:17 EDT OPTR Optimer downgraded to Neutral from Outperform at RW Baird Subscribe for More Information May 9, 2013 16:19 EDT OPTR Optimer reports Q1 EPS (65c), consensus (42c) Reports Q1 revenue $19.4M, consensus $21.09M. Sign up for a free trial to see the rest of the stories you've been missing.